Detalhe da pesquisa
1.
Challenges in interpreting cytokine data in COVID-19 affect patient care and management.
PLoS Biol
; 19(8): e3001373, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34358229
2.
Janus kinase inhibitors for alopecia areata.
J Am Acad Dermatol
; 89(2S): S29-S32, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37591562
3.
Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata.
Qual Life Res
; 32(5): 1319-1327, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35821174
4.
A qualitative interview study to explore adolescents' experience of alopecia areata and the content validity of sign/symptom patient-reported outcome measures.
Br J Dermatol
; 186(5): 849-860, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34811721
5.
Development of the alopecia areata scale for clinical use: Results of an academic-industry collaborative effort.
J Am Acad Dermatol
; 86(2): 359-364, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34474079
6.
Eyebrows Are Important in the Treatment of Alopecia Areata.
J Investig Dermatol Symp Proc
; 20(1): S37-S40, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33099382
7.
The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms.
J Investig Dermatol Symp Proc
; 20(1): S71-S77, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33099392
8.
JAK inhibitors in dermatology: The promise of a new drug class.
J Am Acad Dermatol
; 76(4): 736-744, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28139263
9.
Reply to: "Special editorial: When prescribing Janus Kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration's September 1, 2021, data safety communication".
J Am Acad Dermatol
; 87(2): 498-499, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35398217
10.
The close resemblance between patients with severe alopecia areata and those with cancer: What hair tells us about wellness or grave illness.
J Am Acad Dermatol
; 86(3): e125-e126, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34699912
11.
Tofacitinib for the treatment of alopecia areata and variants in adolescents.
J Am Acad Dermatol
; 76(1): 29-32, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27816292
12.
Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.
J Am Acad Dermatol
; 76(1): 22-28, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27816293
13.
It is all alopecia areata: It is time to abandon the terms alopecia totalis and alopecia universalis.
J Am Acad Dermatol
; 87(5): e149-e151, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34678234
14.
Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.
J Am Acad Dermatol
; 77(4): 675-682.e1, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28823882
15.
Ultraviolet light in combination with other therapies for vitiligo: Synergy or necessity?
J Am Acad Dermatol
; 84(1): e63-e64, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32891783
16.
Combination tofacitinib and oral minoxidil treatment for severe alopecia areata.
J Am Acad Dermatol
; 85(3): 743-745, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31499158
17.
Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review.
J Am Acad Dermatol
; 75(4): 806-812.e3, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27436156
18.
Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate.
J Am Acad Dermatol
; 73(3): 395-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26194706
19.
IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans.
J Allergy Clin Immunol
; 144(6): 1731-1734.e1, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31470035
20.
Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata.
J Am Acad Dermatol
; 80(6): 1778-1779, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30502414